Effects of Aerobic Exercise Training on Cardiac Renin-Angiotensin System in an Obese Zucker Rat Strain

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Barretti, Diego Lopes Mendes ^a   Magalhães, Flávio de Castro ^a   Fernandes, Tiago ^a   do Carmo, Everton Crivoi ^a   Rosa, Kaleizu Teodoro ^a   Irigoyen, Maria Claudia ^a   Negrão, Carlos Eduardo ^a   Oliveira, Edilamar Menezes ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; TRIACYLGLYCEROL;

AEROBIC EXERCISE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ELECTROCARDIOGRAM; ENZYME ACTIVITY; ENZYME ASSAY; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE; HEART RATE; HEART VENTRICLE HYPERTROPHY; HYPERACTIVITY; INTRAABDOMINAL FAT; MALE; METABOLIC PARAMETERS; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWIMMING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; ECHOCARDIOGRAPHY; HEART; HEART RATE; MALE; MYOSIN HEAVY CHAINS; OBESITY; PEPTIDYL-DIPEPTIDASE A; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, ZUCKER; REAL-TIME POLYMERASE CHAIN REACTION; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84867406075     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046114     Document Type: Article

References (43)

1. Deitel M, (2003) Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg 13: 329-330.
2. de Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH, (1994) Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 23: 600-606.
3. Avelar E, Cloward TV, Walker JM, Farney RJ, Strong M, et al. (2007) Left ventricular hypertrophy in severe obesity: interactions among blood pressure, nocturnal hypoxemia, and body mass. Hypertension 49: 34-39.
4. Abel ED, Litwin SE, Sweeney G, (2008) Cardiac remodeling in obesity. Physiol Rev 88: 389-419.
5. Dostal DE, (2000) The cardiac renin-angiotensin system: novel signaling mechanisms related to cardiac growth and function. Regul Pept 91: 1-11.
6. Paul M, Wagner J, Dzau VJ, (1993) Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction. J Clin Invest 91: 2058-2064.
7. Duarte J, Martinez A, Bermejo A, Vera B, Gamez MJ, et al. (1999) Cardiovascular effects of captopril and enalapril in obese Zucker rats. Eur J Pharmacol 365: 225-232.
8. Toblli JE, Cao G, DeRosa G, Di Gennaro F, Forcada P, (2004) Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats. Am J Hypertens 17: 172-180.
9. Adam A, Leclair P, Montpas N, Koumbadinga GA, Bachelard H, et al. Altered cardiac bradykinin metabolism in experimental diabetes caused by the variations of angiotensin-converting enzyme and other peptidases. Neuropeptides 44: 69-75.
10. Huang TH, He L, Qin Q, Yang Q, Peng G, et al. (2008) Salacia oblonga root decreases cardiac hypertrophy in Zucker diabetic fatty rats: inhibition of cardiac expression of angiotensin II type 1 receptor. Diabetes Obes Metab 10: 574-585.
11. du Toit EF, Nabben M, Lochner A, (2005) A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury. Basic Res Cardiol 100: 346-354.
12. Pereira MG, Ferreira JC, Bueno CR Jr, Mattos KC, Rosa KT, et al. (2009) Exercise training reduces cardiac angiotensin II levels and prevents cardiac dysfunction in a genetic model of sympathetic hyperactivity-induced heart failure in mice. Eur J Appl Physiol 105: 843-850.
13. Carroll JF, Kyser CK, (2002) Exercise training in obesity lowers blood pressure independent of weight change. Med Sci Sports Exerc 34: 596-601.
14. Berggren JR, Boyle KE, Chapman WH, Houmard JA, (2008) Skeletal muscle lipid oxidation and obesity: influence of weight loss and exercise. Am J Physiol Endocrinol Metab 294: E726-732.
15. Fernandes T, Hashimoto NY, Magalhaes FC, Fernandes FB, Casarini DE, et al. (2011) Aerobic Exercise Training-Induced Left Ventricular Hypertrophy Involves Regulatory MicroRNAs, Decreased Angiotensin-Converting Enzyme-Angiotensin II, and Synergistic Regulation of Angiotensin-Converting Enzyme 2-Angiotensin (1-7). Hypertension 58: 182-189.
16. Medeiros A, Oliveira EM, Gianolla R, Casarini DE, Negrao CE, et al. (2004) Swimming training increases cardiac vagal activity and induces cardiac hypertrophy in rats. Braz J Med Biol Res 37: 1909-1917.
17. O'Rourke RA, Hanrath P, Henry WN, Hugenholtz PG, Pisa Z, et al. (1984) [Report of the Joint Committee of the International Society and Federation of Cardiology and the World Health Organization on the recommendation for the standardization of quantitation of M-mode echocardiography]. Arch Inst Cardiol Mex 54: 405-409.
18. Alves MF, Araujo MC, Juliano MA, Oliveira EM, Krieger JE, et al. (2005) A continuous fluorescent assay for the determination of plasma and tissue angiotensin I-converting enzyme activity. Braz J Med Biol Res 38: 861-868.
19. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
20. Kopelman PG, (2000) Obesity as a medical problem. Nature 404: 635-643.
21. Howard BV, Ruotolo G, Robbins DC, (2003) Obesity and dyslipidemia. Endocrinol Metab Clin North Am 32: 855-867.
22. Murphy NF, MacIntyre K, Stewart S, Hart CL, Hole D, et al. (2006) Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart J 27: 96-106.
23. Mosconi E, Fontanella M, Sima DM, Van Huffel S, Fiorini S, et al. (2011) Investigation of adipose tissues in Zucker rats using in vivo and ex vivo magnetic resonance spectroscopy. J Lipid Res 52: 330-336.
24. Mathe D, (1995) Dyslipidemia and diabetes: animal models. Diabete Metab 21: 106-111.
25. Schonfeld G, Felski C, Howald MA, (1974) Characterization of the plasma lipoproteins of the genetically obese hyperlipoproteinemic Zucker fatty rat. J Lipid Res 15: 457-464.
26. Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, et al. (2000) Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA 284: 311-318.
27. Toblli JE, Cao G, Rivas C, DeRosa G, Domecq P, (2006) Angiotensin-converting enzyme inhibition reduces lipid deposits in myocardium and improves left ventricular function of obese zucker rats. Obesity (Silver Spring) 14: 1586-1595.
28. Gupta MP, (2007) Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. J Mol Cell Cardiol 43: 388-403.
29. Filho AG, Ferreira AJ, Santos SH, Neves SR, Silva Camargos ER, et al. (2008) Selective increase of angiotensin(1-7) and its receptor in hearts of spontaneously hypertensive rats subjected to physical training. Exp Physiol 93: 589-598.
30. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, et al. (2004) Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 287: R943-949.
31. Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, et al. (2005) Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45: 356-362.
32. Crary GS, Swan SK, O'Donnell MP, Kasiske BL, Katz SA, et al. (1995) The angiotensin II receptor antagonist losartan reduces blood pressure but not renal injury in obese Zucker rats. J Am Soc Nephrol 6: 1295-1299.
33. Harker CT, O'Donnell MP, Kasiske BL, Keane WF, Katz SA, (1993) The renin-angiotensin system in the type II diabetic obese Zucker rat. J Am Soc Nephrol 4: 1354-1361.
34. Alonso-Galicia M, Brands MW, Zappe DH, Hall JE, (1996) Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. Hypertension 28: 1047-1054.
35. Stepp DW, Boesen EI, Sullivan JC, Mintz JD, Hair CD, et al. (2007) Obesity augments vasoconstrictor reactivity to angiotensin II in the renal circulation of the Zucker rat. Am J Physiol Heart Circ Physiol 293: H2537-2542.
36. Gembardt F, Heringer-Walther S, van Esch JH, Sterner-Kock Dvm A, van Veghel R, et al. (2008) Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors. Faseb J.
37. Galderisi M, de Divitiis O, (2008) Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 51: 523-531.
38. Suzuki J, Iwai M, Nakagami H, Wu L, Chen R, et al. (2002) Role of angiotensin II-regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation. Circulation 106: 847-853.
39. Siddiqui AH, Ali Q, Hussain T, (2009) Protective role of angiotensin II subtype 2 receptor in blood pressure increase in obese Zucker rats. Hypertension 53: 256-261.
40. Peterson JM, Bryner RW, Sindler A, Frisbee JC, Alway SE, (2008) Mitochondrial Apoptotic Signaling Is Elevated in Cardiac but Not Skeletal Muscle in the Obese Zucker Rat and Is Reduced with Aerobic Exercise. J Appl Physiol.
41. Goldenberg I, Grossman E, Jacobson KA, Shneyvays V, Shainberg A, (2001) Angiotensin II-induced apoptosis in rat cardiomyocyte culture: a possible role of AT1 and AT2 receptors. J Hypertens 19: 1681-1689.
42. Chappel MC, Ferrario CM, (2006) ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1-7). Kidney Int 70: 8-10.
43. van der Merwe L, Cloete R, Revera M, Heradien M, Goosen A, et al. (2008) Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy. Hum Genet 124: 57-61.